Today: 27 June 2026
Apple Stock’s Next Big Move May Come Monday As WWDC Puts Siri On Trial
7 June 2026
2 mins read

Apple Stock’s Next Big Move May Come Monday As WWDC Puts Siri On Trial

New York, June 7, 2026, 12:02 EDT

Apple Inc. heads into Monday’s Worldwide Developers Conference with its stock near recent highs but no longer floating above the broader market. Friday’s tech selloff turned what might have been a product-news week into a sharper test of whether Apple can show a credible artificial intelligence plan.

U.S. markets are shut for the weekend. Apple last traded at $307.34 on Friday, down 1.25% on the day, and its market value stood at about $4.53 trillion. From the prior Friday’s $312.06 close, the shares fell about 1.5% for the week.

That matters now because WWDC, Apple’s annual software and developer conference, starts Monday, June 8. Apple said the keynote begins at 10 a.m. PDT and will show updates to its platforms, including artificial intelligence, or software that can generate, summarize or act on information.

The stock setup is tight. Options traders — investors using contracts to hedge or bet on a share move — are pricing in a swing of about 3% by the end of the week, Investopedia reported. That would put Apple above $317 on the upside or below $298 on the downside from Friday’s close.

The main question is Siri. Analysts expect Apple to show a more capable version of its voice assistant after earlier delays hurt confidence in the company’s AI rollout. A clearer release timetable could help; another vague demo would not.

Wedbush analyst Dan Ives kept an Outperform rating and a $400 target on Apple ahead of the event. “We expect fireworks with the long-awaited AI strategy,” Ives said, adding that WWDC is “a pivotal moment” for Apple’s future. He also said AI services could add $75 to $100 to the share price over time. Benzinga

Goldman Sachs analyst Michael Ng expects the new Siri to include on-screen awareness and personal context, allowing it to use information from apps such as Messages, Calendar, Photos and Notes, according to GuruFocus. That is the kind of feature investors are watching because it could tie AI more deeply to the iPhone rather than leave Apple chasing chatbot rivals.

There is a competitive edge to the event, too. Alphabet is relevant because analysts have pointed to Google’s Gemini model as part of the expected Siri upgrade. Nvidia is the market comparison because AI enthusiasm has been led by chip and infrastructure stocks, not Apple’s device-and-services model.

The tape around Apple is not calm. Reuters reported that the Nasdaq Composite fell 4.18% on Friday and the S&P 500 lost 2.64%, while Nvidia dropped 6.2%, after a strong May jobs report revived worries about higher U.S. interest rates. “The dam just broke today,” Ryan Detrick, chief market strategist at Carson Group, told Reuters. Reuters

But the bar may already be high. UBS analyst David Vogt has a Neutral rating and a $296 price target, and Barron’s reported that UBS does not expect WWDC to meaningfully lift the stock unless Apple delivers surprises. The downside case is simple: Siri looks incremental, release dates stay fuzzy, and investors rotate away from richly valued tech if rates rise again.

The week ahead gives Apple two tests. The first is Monday’s keynote. The second is the macro backdrop: the U.S. consumer price index, a government measure of price changes, is due Wednesday at 8:30 a.m. EDT for May. A hotter reading could keep pressure on growth stocks, including Apple, even if WWDC lands well.

For now, Apple’s stock story is less about a single feature than proof of direction. Investors want to see whether the company can make AI useful inside its own ecosystem, not just promise it.

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets.

Stock Market Today

  • Generate Biomedicines Stock Surges Above IPO Price with Volume Spike
    June 27, 2026, 11:39 AM EDT. Generate Biomedicines (NASDAQ:GENB) shares closed Friday at $16.47, surpassing their $16 IPO price, with a 13.7% gain since June 18. The stock hit a 52-week high of $17.42 this week, supported by a volume of 4.10 million shares-4.4 times the average. The company raised $400 million at $16 per share in February, currently valued at about $2.11 billion. With $516.6 million in cash and equivalents as of March 31, Generate can fund operations through H1 2028 but expects to seek additional capital for long-term growth. Clinical developments include advancing GB-0895 for severe asthma in Phase 3 and pipeline progress for COPD treatments. Collaboration revenue dropped to $7.2 million in Q1. The stock's strength tracked gains in the biotech sector, with the SPDR S&P Biotech ETF up 2.5% on Friday and over 13% in June.

Latest articles

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

27 June 2026
Uber surged 5.47% to $76.20 on Friday with trading volume 3.46 times its 65-day average, as investors weighed tighter U.S. driver background checks set to remove tens of thousands of gig workers starting Monday—raising potential impacts on trips, wait times, and margins while the stock remains 25.3% below its 52-week high.
Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

27 June 2026
Honeywell’s two-for-one split launches Monday, giving investors one Honeywell Technologies share and one Honeywell Aerospace (HONA) share for every two old shares, with the combined package valued at $464.42 at Friday’s close; both stocks debut as separate S&P 500 members, while HONA joins the S&P 100, setting up a pivotal test for holders as the market reopens.
Generate Biomedicines stock ends week back above IPO price as volume jumps

Generate Biomedicines stock ends week back above IPO price as volume jumps

27 June 2026
Generate Biomedicines (NASDAQ:GENB) surged 13.7% since June 18 to close Friday at $16.47—above its $16 IPO price—with heavy volume and a $2.11B market cap, as investors weigh its $516.6M cash pile, ongoing clinical trial risks, and lack of product revenue, while sector momentum lifts biotech stocks.
Snowflake (NYSE:SNOW) finishes up for the week after Russell rebalance trading

Snowflake (NYSE:SNOW) finishes up for the week after Russell rebalance trading

27 June 2026
Snowflake Inc (NYSE:SNOW) surged 9.65% to $248.96 on Friday with trading volume five times the weekly average, driven by FTSE Russell’s U.S. index reconstitution, turning a negative week into a 7.2% gain since June 18, as investors await whether the stock can hold above its previous $225.95–$230.41 range when index-driven liquidity fades next week.
Redwire Shares Sink Despite Space Strawberry News
Previous Story

Redwire Shares Sink Despite Space Strawberry News

POET Technologies Stock Drops Sharply as Investors Watch
Next Story

POET Technologies Stock Just Took a Hit — Why Monday Could Decide the Next Move

Go toTop